However, certain compounds, like Gingko extract, N106 (specific for SUMO-activating enzyme E1 ligase) [68,69], or SENP2 inhibitors, like 1,2,5-Oxadiazole [70], can modulate SUMOylation and may be beneficial in diabetes. Here, SENP2 is linked to diabetes mellitus.